|
|
Volumn 14, Issue , 2016, Pages 1-2
|
|
From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD19 ANTIBODY;
CHIMERIC ANTIGEN RECEPTOR;
IMMUNOSUPPRESSIVE AGENT;
JCAR 015;
MONOCLONAL ANTIBODY;
TOCILIZUMAB;
UNCLASSIFIED DRUG;
LYMPHOCYTE ANTIGEN RECEPTOR;
TUMOR ANTIGEN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
AKINETIC MUTISM;
CANCER IMMUNOTHERAPY;
CELLULAR IMMUNITY;
CHEMORADIOTHERAPY;
CLINICAL TRIAL (TOPIC);
CYTOKINE RELEASE;
CYTOKINE RELEASE SYNDROME;
DELIRIUM;
DOWN REGULATION;
DRUG EFFICACY;
DRUG SAFETY;
DYSPHASIA;
EDITORIAL;
HEMATOLOGIC MALIGNANCY;
HEMATOLOGY;
HUMAN;
HYPOXIA;
LYMPHOCYTOPENIA;
MULTIPLE MYELOMA;
NEUROTOXICITY;
PATIENT SAFETY;
PRIORITY JOURNAL;
T CELL LYMPHOMA;
T LYMPHOCYTE;
TUMOR MICROENVIRONMENT;
ADOPTIVE IMMUNOTHERAPY;
ADVERSE EFFECTS;
BIOLOGICAL THERAPY;
GENE THERAPY;
GENETICS;
IMMUNOLOGY;
METABOLISM;
NEOPLASMS;
PROCEDURES;
ANTIGENS, NEOPLASM;
CELL- AND TISSUE-BASED THERAPY;
GENETIC THERAPY;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
NEOPLASMS;
RECEPTORS, ANTIGEN, T-CELL;
|
|
EID: 85003952268
PISSN: None
EISSN: 23523964
Source Type: Journal
DOI: 10.1016/j.ebiom.2016.11.037 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|